All Tutorials

114 articles in this topic

Purinergic Signaling as a Longevity Target: Therapeutic Frontiers and Systems-Level Mechanisms
Longevity & Aging
Premium

Purinergic Signaling as a Longevity Target: Therapeutic Frontiers and Systems-Level Mechanisms

Explore the advanced molecular architecture of purinergic stress signaling — from transcriptional reprogramming and metabolic crosstalk to emerging therapeutic strategies targeting CD38, P2X7, and the ectonucleotidase axis in aging.

TutorialAdvanced
Sep 11, 2026 0
ATP as Danger Signal: The Molecular Machinery of Purinergic Stress Responses
Longevity & Aging
Premium

ATP as Danger Signal: The Molecular Machinery of Purinergic Stress Responses

Go beneath the surface of cellular alarm signaling — explore the receptor subtypes, enzymatic pathways, and feedback loops that determine whether ATP triggers inflammation or resolution in aging tissue.

TutorialIntermediate
Sep 10, 2026 0
Your Cells' Secret Distress Signal: Understanding Purinergic Signaling
Longevity & Aging
Premium

Your Cells' Secret Distress Signal: Understanding Purinergic Signaling

Discover how your cells send out tiny chemical SOS messages when under stress — and why this ancient communication system is a key player in how we age.

TutorialBeginner
Sep 9, 2026 0
SNPs and SNP Panels: Reading a Curated Variant Report Without Over-Reading It
Longevity & Aging
Premium

SNPs and SNP Panels: Reading a Curated Variant Report Without Over-Reading It

A clinical guide to what common single-nucleotide variants and curated panels genuinely deliver — pharmacogenomic phenotypes, HLA risk types, polygenic percentiles — and the structural reasons a negative panel in a symptomatic patient tells you almost nothing.

TutorialAdvanced
Sep 7, 2026 0
Reading a Pharmacogenomic Report: The Gene–Drug Pairs That Actually Change a Prescription
Longevity & Aging
Premium

Reading a Pharmacogenomic Report: The Gene–Drug Pairs That Actually Change a Prescription

A clinician's guide to interpreting metabolizer phenotype labels, the gene–drug pairs with evidence strong enough to act on today, and why a genotype describes capacity rather than current enzyme activity.

TutorialAdvanced
Sep 6, 2026 0
Pathogenic, Benign, or Uncertain: How a Variant Gets Its Verdict — and What Each Verdict Licenses
Longevity & Aging
Premium

Pathogenic, Benign, or Uncertain: How a Variant Gets Its Verdict — and What Each Verdict Licenses

A clinician's guide to reading the classification column on a genomic report: what dbSNP, gnomAD and ClinVar each contribute, why a variant of uncertain significance must never drive management, and how to explain penetrance to a patient who has just been called 'pathogenic'.

TutorialAdvanced
Sep 6, 2026 0
From Blood Draw to Variant List: What the Genomic Pipeline Does, and Where It Fails Quietly
Longevity & Aging
Premium

From Blood Draw to Variant List: What the Genomic Pipeline Does, and Where It Fails Quietly

A clinician's guide to the five stages between a sample and a genomic report — what each accomplishes, why millions of variants is a normal result, and how a poorly read region becomes a falsely reassuring negative.

TutorialAdvanced
Sep 6, 2026 0
What a 30× Whole Genome Sequence Actually Is — and What It Still Cannot Tell You
Longevity & Aging
Premium

What a 30× Whole Genome Sequence Actually Is — and What It Still Cannot Tell You

A clinical reading guide to 30× whole genome sequencing: what the depth figure means, how it differs from a SNP array and an exome, and the specific variant classes a normal genome report does not exclude.

TutorialAdvanced
Sep 6, 2026 0
Heparan Sulfate Proteoglycans: Engineering the Aging Extracellular Code
Longevity & Aging
Premium

Heparan Sulfate Proteoglycans: Engineering the Aging Extracellular Code

A deep mechanistic exploration of how HSPG sulfation patterns, heparanase signaling, and proteoglycan-receptor crosstalk orchestrate aging — and the cutting-edge therapeutic strategies aiming to reverse it.

TutorialAdvanced
Sep 4, 2026 0
Heparan Sulfate Proteoglycans: The Molecular Gatekeepers of Cellular Aging
Longevity & Aging
Premium

Heparan Sulfate Proteoglycans: The Molecular Gatekeepers of Cellular Aging

Go beneath the surface to understand how HSPGs regulate growth factor signaling, inflammation, and tissue repair — and why their structural decline drives aging at the molecular level.

TutorialIntermediate
Sep 3, 2026 0
The Cellular Glue That Ages With You: An Introduction to Heparan Sulfate Proteoglycans
Longevity & Aging
Premium

The Cellular Glue That Ages With You: An Introduction to Heparan Sulfate Proteoglycans

Discover the surprising sugar-protein molecules coating your cells — and why their decline may be a hidden driver of aging.

TutorialBeginner
Sep 2, 2026 0
Methyl Donor Flux, DNMT Kinetics, and Epigenetic Clock Reprogramming
Longevity & Aging
Premium

Methyl Donor Flux, DNMT Kinetics, and Epigenetic Clock Reprogramming

A mechanistic deep dive into how one-carbon metabolic flux governs DNMT fidelity, clock CpG methylation dynamics, and emerging interventions targeting epigenetic age reversal.

TutorialAdvanced
Aug 29, 2026 0
PreviousPage 2 of 10Next